A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Clinical trial NCT07488676 · RECRUITING

Trial details

NCT number: NCT07488676
Sponsor: Astellas Pharma Global Development, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Pancreatic Adenocarcinoma

Start date: 2026-05-04
Primary completion: 2029-07-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.